Pradaxa 150 mg
- Brand: Boehringer Ingelheim
- Product Code: BO_PDX_150
- Availability: In Stock
Contain the active ingredient : Dabigatran etexilate, which is a type of medicine called a direct thrombin inhibitor. It is used to stop blood clots forming within the blood vessels.
Blood clots usually only form to stop bleeding that has occurred as a result of injury to tissue in the body. However, after hip or knee replacement surgery there is a risk of blood clots forming in the blood vessels. This risk is increased by being immobile for long periods of time following the surgery, as a result of slowed blood flow in the leg and pelvic veins. A clot that forms in the veins of the leg is called a deep vein thrombosis. These dangerous blood clots can travel to the lungs, causing a serious condition called a pulmonary embolism.
People with a type of fast irregular heartbeat called atrial fibrillation (AF) are also at risk of blood clots forming, both within the heart and in the blood vessels. This is because the abnormal heart rhythm disrupts blood flow in the blood vessels. Clots in the heart can detach and travel to the brain, causing a stroke. Clots can also travel in and block other blood vessels around the body.
The blood clotting process is complicated. When blood begins to clot, a cascade of chemicals is activated within the body, resulting in the formation of an enzyme called thrombin. Thrombin is central to the complete process of blood clotting. It causes a protein called fibrinogen to be converted into another called fibrin. Fibrin binds blood cells called platelets together, and this forms the blood clot.
Dabigatran works by binding to thrombin in the clotting process described above and blocking its action. This stops the formation of fibrin, the essential component of blood clots. Dabigatran can therefore prevent blood clots from developing.
What is it used for?
Preventing dangerous blood clots in the veins (venous thromboembolism) in adults who have undergone elective total hip or knee replacement surgery.
Treating blood clots in the veins of the legs (deep vein thrombosis) or in the lungs (pulmonary embolism).
Preventing recurrent deep vein thrombosis and pulmonary embolism.
Preventing the formation of blood clots that can cause a stroke or blockage of other blood vessels in the body in people with a type of irregular heartbeat called non-valvular atrial fibrillation (AF). This medicine is licensed to prevent these types of blood clots in people with AF who have one or more of the following additional risk factors:
- a history of stroke, mini-stroke (TIA) or blood clots
- heart failure
- age over 75 years
- high blood pressure.
Size : 3 x 10's = 30 tablets / box
English instruction inside the box